ConvaTec Group

CTECHealthcare
275.60GBX
-0.07%
Market Cap
5.63B
Volume
7.01M
106% of avg
P/E Ratio
21.20
EPS (TTM)
0.13
Beta
0.66
Day Range
273.40p - 276.40p
52 Week Range
211.80p275.60p276.40p
275.60p

Upcoming Events

22 May 2025
Annual General Meeting
July 29, 2025
Interim results for the 6 months ended 30 June 2025
High Impact Event
2026
Randomised controlled trials for InnovaMatrix® in DFU and VLU expected to report
High Impact Event
CTEC
NEUTRAL

ConvaTec Group Provides Regulatory Update

The healthcare company has announced a regulatory filing regarding a change in shareholding.

CTEC
NEUTRAL

ConvaTec Group Announces Regulatory Filing

The healthcare company has made a regulatory filing, but no further details are provided.

CTEC
NEUTRAL

ConvaTec Group Announces Regulatory Filing

The healthcare company has filed a regulatory announcement, but no further details are provided.

CTEC
NEUTRAL

ConvaTec Responds to LCD Postponement in US

The healthcare company welcomes the postponement of LCDs in the US, which will allow continued access to its InnovaMatrix product for Medicare patients.

CTEC
NEUTRAL

ConvaTec Announces Change in Major Shareholding

The healthcare company has reported a change in major shareholding, with FIL Limited increasing its stake to over 6%.

CTEC
NEUTRAL

ConvaTec Announces Director Share Dealings

The healthcare company has disclosed details of a PDMR's vesting of shares under the long-term incentive plan and subsequent sale of shares to cover tax liabilities.

CTEC
NEUTRAL

ConvaTec CEO Karim Bitar Vests Shares Under Incentive Plans

The healthcare company announced the vesting of shares for its CEO under long-term incentive plans.

CTEC
NEUTRAL

Convatec Group Plc Announces Director/PDMR Shareholding Changes

The medical products and technologies company announces changes to director and PDMR shareholdings through the grant of incentive awards.

CTEC
NEUTRAL

Convatec Group PLC Publishes Annual Report and AGM Notice

The healthcare company has published its annual report and notice of annual general meeting, a routine regulatory update.

CTEC
GOOD

Convatec Reports Strong FY24 Results with Double-Digit Profit Growth

The medical products and technologies group reported strong FY24 results with 7.7% organic revenue growth and 13.7% increase in adjusted EPS. Management expressed confidence in the FY25 outlook, targeting continued growth and margin expansion.